<DOC>
	<DOCNO>NCT01638780</DOCNO>
	<brief_summary>The main objective study investigate resveratrol supplementation improve overall muscle-specific insulin sensitivity type 2 diabetic patient . As secondary objective investigator want investigate whether improved insulin sensitivity attribute improved muscle mitochondrial oxidative capacity reduce intrahepatic cardiac lipid content .</brief_summary>
	<brief_title>Resveratrol Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Resveratrol</mesh_term>
	<criteria>Male sex Age : 4070 year Body fat percentage &gt; 25 , BMI 2735 kg/m2 Diagnosed type 2 diabetes least one year start study Wellcontrolled type 2 diabetic : HBA1C &lt; 8.0 % Oral glucose lower medication ( metformin combination sulfonylurea agent ) Sedentary Not 2 hour sport week No active job require strenuous physical activity Stable dietary habit Willingness abstain resveratrolcontaining food product Unstable body weight ( weight gain loss &gt; 3kg last three month ) Total body fat percentage &lt; 25 % Hemoglobin &lt; 7.8 mmol/l Use anticoagulants Engagement program exercise &gt; 2 hour total per week Impaired kidney and/or hepatic function Creatinine 50100 umol/L Liver enzyme , within 2 time normal range laboratory standard ( ASAT &lt; 60 U/L , ALAT &lt; 70 U/L , Billi &lt; 40 umol/L , gammaGT &lt; 80 U/L ) No diabetes related comorbidities like cardiovascular disease , diabetic foot , polyneuropathy , retinopathy Insulin dependent Diabetic subject Any medical condition except type 2 diabetes mellitus require treatment and/or medication use except metformin combination sulfonylurea agent Intake dietary supplement except multivitamin mineral Current alcohol consumption &gt; 20 grams/day Subjects n't want inform unexpected medical finding screen /study , wish physician inform , participate study . Participation another biomedical study within 1 month first screen visit Any contraindication MRI scanning . These contraindication include patient follow device : Central nervous system aneurysm clip Implanted neural stimulator Implanted cardiac pacemaker defibrillator Cochlear implant Insulin pump Or metal contain corpus aliena eye brain</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>